JBMR plus

HR-pQCT cross-calibration using standard vs. Laplace-Hamming binarization approach.

JBMR plus

Sadoughi S, Subramanian A, Ramil G, Zhou M, Burghardt AJ, Kazakia GJ

HR-pQCT cross-calibration using standard vs. Laplace-hamming Binarization approach.

JBMR plus

Saghi Sadoughi, Aditya Subramanian, Gabby Ramil, Minhao Zhou, Andrew J Burghardt, Galateia J Kazakia

Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone.

JBMR plus

Lung H, Wentworth KL, Moody T, Zamarioli A, Ram A, Ganesh G, Kang M, Ho S, Hsiao EC

Wnt Pathway Inhibition with the Porcupine Inhibitor LGK974 Decreases Trabecular Bone but not Fibrosis in a Murine Model with Fibrotic Bone.

JBMR plus

Hsuan Lung, Kelly L Wentworth, Tania Moody, Ariane Zamarioli, Apsara Ram, Gauri Ganesh, Misun Kang, Sunita Ho, Edward C Hsiao

Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.

JBMR plus

Ward LM, Högler W, Glorieux FH, Portale AA, Whyte MP, Munns CF, Nilsson O, Simmons JH, Padidela R, Namba N, Cheong HI, Sochett E, Muroya K, Tanaka H, Pitukcheewanont P, Gottesman GS, Biggin A, Perwad F, Chen A, Lawrence Merritt Ii J, Imel EA

Burosumab versus conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period.

JBMR plus

Leanne M Ward, Wolfgang Högler, Francis H Glorieux, Anthony A Portale, Michael P Whyte, Craig F Munns, Ola Nilsson, Jill H Simmons, Raja Padidela, Noriyuki Namba, Hae Il Cheong, Etienne Sochett, Koji Muroya, Hiroyuki Tanaka, Pisit Pitukcheewanont, Gary S Gottesman, Andrew Biggin, Farzana Perwad, Angel Chen, J Lawrence Merritt, Erik A Imel

Introduction: Special Issue on Vitamin D Dedicated to the Memory of Anthony W Norman.

JBMR plus

Bouillon R, Haussler M, Bikle D, Christakos S, Welsh J

Pages